• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

论蛋白质构象改变在帕金森病中所起的关键作用。

On the key role played by altered protein conformation in Parkinson's disease.

作者信息

Agnati L F, Baldelli E, Andreoli N, Woods A S, Vellani V, Marcellino D, Guidolin D, Fuxe K

机构信息

Section of Physiology, Department of Biomedical Sciences, University of Modena, 41100 Modena, Italy.

出版信息

J Neural Transm (Vienna). 2008 Sep;115(9):1285-99. doi: 10.1007/s00702-008-0072-1. Epub 2008 Jun 5.

DOI:10.1007/s00702-008-0072-1
PMID:18528629
Abstract

On the basis of the previously proposed hierarchic organisation of the central nervous system (CNS) and of its syntropic behaviour, a view of neurodegenerative diseases focusing on the assemblage of abnormal multimeric proteins (pathologic protein mosaics (PMs)) is proposed. Thus, the main focus of the present paper is on Parkinson's disease (PD) as a neurodegenerative disease, which has as crucial feature protein conformational alterations and formation of pathological PMs. Two interconnected cellular dysfunctions are discussed as main pathogenic factors of PD syndromes, namely mitochondrial deficits (i.e. energy failure, especially critical for Substantia Nigra DA neurons) and conformational protein alterations (due to genetic or environmental causes). Conformational protein alterations can trigger pathological phenomena via the loss and/or the gain of new functions. In particular, altered proteins can lead to the formation of abnormal PMs, which can, inter alia, cause distortion of cellular structures, toxic functions and/or formation of improper membrane ion channels. In view of the fact that disordered proteins can easily acquire unwanted conformation, the "disorder index" (DI) for proteins involved in PD has been evaluated. It has been found that both alpha-synuclein and tau-protein have high DI. This datum is in agreement with the observation that these two proteins synergistically promote polymerisation of each other into amyloid fibrils, favouring the formation of Lewy bodies.

摘要

基于先前提出的中枢神经系统(CNS)的层级组织及其同向行为,本文提出了一种关于神经退行性疾病的观点,该观点聚焦于异常多聚体蛋白(病理性蛋白镶嵌体(PMs))的聚集。因此,本文的主要重点是帕金森病(PD)这一神经退行性疾病,其关键特征是蛋白质构象改变和病理性PMs的形成。本文讨论了两种相互关联的细胞功能障碍,它们是PD综合征的主要致病因素,即线粒体缺陷(即能量衰竭,对黑质多巴胺能神经元尤为关键)和构象性蛋白质改变(由遗传或环境原因引起)。构象性蛋白质改变可通过新功能的丧失和/或获得引发病理现象。特别是,改变的蛋白质可导致异常PMs的形成,这尤其会导致细胞结构扭曲、毒性功能和/或不适当的膜离子通道形成。鉴于无序蛋白质容易获得不需要的构象,已对参与PD的蛋白质的“无序指数”(DI)进行了评估。已发现α-突触核蛋白和tau蛋白均具有高DI。这一数据与以下观察结果一致,即这两种蛋白质协同促进彼此聚合成淀粉样纤维,有利于路易小体的形成。

相似文献

1
On the key role played by altered protein conformation in Parkinson's disease.论蛋白质构象改变在帕金森病中所起的关键作用。
J Neural Transm (Vienna). 2008 Sep;115(9):1285-99. doi: 10.1007/s00702-008-0072-1. Epub 2008 Jun 5.
2
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.大鼠黑质中α-突触核蛋白的过表达导致多巴胺能神经元丧失、α-突触核蛋白磷酸化及半胱天冬酶-9激活:类似于帕金森病的致病变化。
J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x.
3
Alteration in alpha-synuclein mRNA expression in Parkinson's disease.帕金森病中α-突触核蛋白mRNA表达的改变。
Mov Disord. 2004 Feb;19(2):162-70. doi: 10.1002/mds.10683.
4
Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.α-突触核蛋白异构体与帕金森病路易小体形成细胞模型的探索
Cell Cycle. 2006 Sep;5(18):2082-6. doi: 10.4161/cc.5.18.3209. Epub 2006 Sep 15.
5
Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.泛素羧基末端水解酶L1对帕金森病α-突触核蛋白过表达小鼠模型的影响。
J Neurochem. 2009 Feb;108(4):932-44. doi: 10.1111/j.1471-4159.2008.05827.x. Epub 2009 Jan 7.
6
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.蛋白质聚集在阿尔茨海默病和帕金森病线粒体功能障碍及神经退行性变中的作用。
Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21.
7
TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.散发性帕金森病中路易小体内的TorsinA积聚。
Brain Res. 2000 Sep 22;877(2):379-81. doi: 10.1016/s0006-8993(00)02702-5.
8
Fas-associated factor 1 and Parkinson's disease.Fas相关因子1与帕金森病
Neurobiol Dis. 2008 Sep;31(3):309-15. doi: 10.1016/j.nbd.2008.05.006. Epub 2008 May 29.
9
Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.聚集蛋白结合α-突触核蛋白并调节α-突触核蛋白的纤维化。
Glycobiology. 2005 Dec;15(12):1320-31. doi: 10.1093/glycob/cwj014. Epub 2005 Jul 21.
10
Alpha-synuclein and Parkinson's disease.α-突触核蛋白与帕金森病。
Adv Neurol. 2003;91:165-74.

引用本文的文献

1
Recent advances in our understanding of neurodegeneration.我们对神经退行性变认识的最新进展。
J Neural Transm (Vienna). 2009 Sep;116(9):1111-62. doi: 10.1007/s00702-009-0240-y. Epub 2009 Jun 5.
2
Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.衰老的费希尔344大鼠肌间神经丛中α-突触核蛋白免疫阳性聚集体
Exp Neurol. 2009 Nov;220(1):109-19. doi: 10.1016/j.expneurol.2009.07.025. Epub 2009 Aug 5.
3
Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

本文引用的文献

1
Aspects of neural plasticity in the central nervous system-VII. Theoretical aspects of brain communication and computation.中枢神经系统神经可塑性的若干方面——VII. 大脑通信与计算的理论方面。
Neurochem Int. 1990;16(4):479-500. doi: 10.1016/0197-0186(90)90008-h.
2
Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.丝氨酸-129位点的磷酸化而非磷酸模拟物S129E/D可抑制α-突触核蛋白的纤维化。
J Biol Chem. 2008 Jun 13;283(24):16895-905. doi: 10.1074/jbc.M800747200. Epub 2008 Mar 14.
3
Genetic factors involved in the pathogenesis of Parkinson's disease.
学习与神经退行性变中的常见关键信号:聚焦于兴奋性氨基酸、β-淀粉样肽和α-突触核蛋白。
J Neural Transm (Vienna). 2009 Aug;116(8):953-74. doi: 10.1007/s00702-008-0150-4. Epub 2008 Nov 19.
帕金森病发病机制中的遗传因素。
Brain Res Rev. 2008 Aug;58(2):354-64. doi: 10.1016/j.brainresrev.2008.02.001. Epub 2008 Feb 11.
4
Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).PTEN诱导激酶-1(PINK1)神经保护机制的生化方面
J Neurochem. 2008 Apr;105(1):18-33. doi: 10.1111/j.1471-4159.2008.05249.x. Epub 2008 Jan 23.
5
Substrate specificity and redox potential of AhpC, a bacterial peroxiredoxin.细菌过氧化物还原酶AhpC的底物特异性和氧化还原电位
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8209-14. doi: 10.1073/pnas.0708308105. Epub 2007 Dec 28.
6
Understanding neuronal molecular networks builds on neuronal cellular network architecture.对神经元分子网络的理解建立在神经元细胞网络结构的基础之上。
Brain Res Rev. 2008 Aug;58(2):379-99. doi: 10.1016/j.brainresrev.2007.11.002. Epub 2007 Nov 26.
7
Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.细胞外α-突触核蛋白的起源与作用:对帕金森病的影响
J Mol Neurosci. 2008;34(1):17-22. doi: 10.1007/s12031-007-0012-9. Epub 2007 Apr 17.
8
Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains.同型半胱氨酸的变构作用及无序结构域的计算机辅助分析所证明的G蛋白偶联受体中的结构可塑性
Brain Res Rev. 2008 Aug;58(2):459-74. doi: 10.1016/j.brainresrev.2007.10.003. Epub 2007 Oct 22.
9
Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases.
Curr Protein Pept Sci. 2007 Oct;8(5):460-70. doi: 10.2174/138920307782411419.
10
HtrA2 and Parkinson's disease: think PINK?HtrA2与帕金森病:与PINK有关吗?
Nat Cell Biol. 2007 Nov;9(11):1227-9. doi: 10.1038/ncb1107-1227.